BangladeshTaevas Global helps medical devices manufacturers navigate DGDA product registration requirements and enter the Bangladesh market with confidence and full regulatory compliance. From dossier preparation to approval, we manage the entire registration lifec
Our six interconnected pillars give medical devices manufacturers a complete foundation for successful product registration and sustainable market entry in Bangladesh.
We map the full DGDA regulatory framework governing medical devices in Bangladesh, including the Drug Control Ordinance 1982 and applicable DGDA circulars and guidelines. Our team tracks evolving policy changes so your registration strategy stays current and defensible from day one.
Our four-stage engagement takes you from initial scoping through to a fully approved DGDA registration and a commercial launch plan your leadership team can act on immediately.
We begin with a detailed intake session to understand your device, its intended use, existing certifications, and target Bangladesh market segments. Our team conducts an immediate DGDA classification assessment and identifies the precise registration pathway applicable to your product.
This phase produces a written Regulatory Assessment Memo that confirms your device classification under DGDA guidelines, lists all required documents, identifies any gaps in your existing technical file, and sets a realistic timeline and fee estimate for the full registration process. This memo becomes the project charter for all subsequent work.
Bangladesh imports the vast majority of its medical devices, with domestic manufacturing capacity remaining limited to basic consumables and diagnostics. This creates a significant and sustained opportunity for international manufacturers seeking DGDA product registration to supply hospitals, clinics, and diagnostic laboratories across the country.
The Directorate General of Drug Administration has been progressively strengthening its medical device oversight, moving toward a more structured registration and post-market surveillance regime. Companies entering now benefit from establishing early regulatory compliance before stricter enforcement mechanisms are fully implemented.
Bangladesh government health programs, including the Essential Service Delivery program and public hospital expansion initiatives, are driving significant procurement of diagnostic equipment, surgical instruments, and patient monitoring devices. DGDA registration is a prerequisite for participation in government tenders.
Private hospital chains, diagnostic centres, and specialty clinics in Dhaka, Chittagong, and secondary cities are rapidly expanding their medical technology procurement. This private sector growth is accelerating demand for mid-to-high-end imaging, laboratory, and surgical devices that require DGDA registration to be commercially distributed.
Every Taevas Global Product Registration engagement for Bangladesh Medical Devices delivers eight structured outputs that cover regulatory, commercial, and operational dimensions of your market entry.
A written assessment confirming your device classification, applicable DGDA registration pathway, required documentation list, and realistic timeline and cost estimate for the full registration process.
A fully compiled, DGDA-compliant technical dossier including product specifications, clinical evidence summaries, quality certificates, labeling, and all supporting documents required for submission.
A detailed gap analysis comparing your existing technical file and certifications against DGDA requirements, with prioritized remediation actions and document preparation guidance.
A forward-looking compliance calendar covering registration renewal dates, post-market surveillance obligations, variation notification windows, and all recurring DGDA reporting requirements.
A commercial intelligence briefing covering market sizing, demand drivers, channel structure, pricing benchmarks, and public procurement entry points specific to your device category in Bangladesh.
A curated longlist of qualified Bangladesh medical device distributors and agents, with capability profiles, geographic reach, existing brand portfolios, and recommended engagement approach.
An overview of competing products and brands already registered with DGDA in your device category, including pricing intelligence, channel presence, and identified market gaps your product can address.
A mapped overview of key healthcare decision-makers, procurement influencers, clinical opinion leaders, and government health program contacts relevant to your device category in Bangladesh.
You have a CE-marked or FDA-cleared medical device and are evaluating Bangladesh as a new export market. You have no local entity, no existing DGDA relationship, and need a trusted partner to manage the entire registration process from classification through approval. The regulatory complexity and unfamiliar documentation requirements are your primary barriers.
Talk to a Taevas Global regulatory specialist today and get a clear, actionable roadmap for DGDA product registration and medical device market entry in Bangladesh. We handle the complexity so you can focus on building your business.